Literature DB >> 2949828

Suppressor cell activity in melanoma-draining lymph nodes.

D S Hoon, R J Bowker, A J Cochran.   

Abstract

We previously demonstrated that the cells of lymph nodes near to a melanoma respond well to stimulation by mitogens, alloantigens, and interleukin 2 than do nodes further away. In this study we examined suppressor T-cell activity in nodes at different distances from primary melanoma, using a concanavalin A (Con A) suppressor cell assay. Tumor-free regional nodes were classified as proximal, intermediate, and distal relative to primary melanoma. Lymph node lymphocytes (LNL) were stimulated with 50 micrograms/ml Con A for 48-72 h, inactivated, and then mixed with autologous peripheral blood lymphocytes. The peripheral blood lymphocyte-LNL mixtures were stimulated with phytohemagglutinin for 3 days. Proliferation was measured by [3H]thymidine uptake during the final 18 h of culture. In 13 patients, Con A-treated LNL from nodes near to tumor were more suppressive of the peripheral blood lymphocyte response to phytohemagglutinin than those from nodes located further from tumor. T-lymphocyte subset assessment before and after Con A treatment of LNL showed no significant changes in T4:T8 ratios. Con A-induced suppressor cells could be maintained in culture in the presence of recombinant interleukin 2 and retained their suppressive activity. LNL not exposed to Con A and maintained in culture with interleukin 2 did not show suppressor cell activity. Suppressor cell activity thus contributes to the weak immune reactivity of lymph nodes near to melanoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2949828

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells.

Authors:  Ronald J C L M Vuylsteke; Paul A M van Leeuwen; Sybren Meijer; Pepijn G J T B Wijnands; Markwin G Statius Muller; Dirk H Busch; Rik J Scheper; Tanja D de Gruijl
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

2.  Recombinant interleukin-2 treatment in patients with metastatic colorectal cancer: effect on natural cytotoxicity.

Authors:  K G Park; S D Heys; J B Murray; P D Hayes; J A Ashby; C R Franks; O Eremin
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 3.  [Role of the spleen in tumor surgery].

Authors:  U Wolters; H W Keller; H Pichlmaier
Journal:  Langenbecks Arch Chir       Date:  1991

Review 4.  Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.

Authors:  Michael R Olin; G Elizabeth Pluhar; Brian M Andersen; Rob Shaver; Nate N Waldron; Christopher L Moertel
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

5.  An analysis of lymphocyte subsets in the regional lymph nodes of patients with papillary thyroid carcinoma.

Authors:  K Sugino
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Prevention by alpha-difluoromethylornithine of skin carcinogenesis and immunosuppression induced by ultraviolet irradiation.

Authors:  H L Gensler
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 7.  Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Authors:  Dale Han; Daniel C Thomas; Jonathan S Zager; Barbara Pockaj; Richard L White; Stanley Pl Leong
Journal:  World J Clin Oncol       Date:  2016-04-10

8.  Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.

Authors:  Antonio Tejera-Vaquerizo; Eduardo Nagore; Susana Puig; Caroline Robert; Philippe Saiag; Paula Martín-Cuevas; Elena Gallego; Enrique Herrera-Acosta; José Aguilera; Josep Malvehy; Cristina Carrera; Andrea Cavalcanti; Ramón Rull; Antonio Vilalta-Solsona; Emilie Lannoy; Celine Boutros; Naima Benannoune; Gorana Tomasic; Philippe Aegerte; Sergi Vidal-Sicart; Josep Palou; L Lúcia Alos; Celia Requena; Víctor Traves; Ángel Pla; Isidro Bolumar; Virtudes Soriano; Carlos Guillén; Enrique Herrera-Ceballos
Journal:  Eur J Cancer       Date:  2015-06-10       Impact factor: 9.162

9.  Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model.

Authors:  John R Ohlfest; Brian M Andersen; Adam J Litterman; Junzhe Xia; Christopher A Pennell; Lauryn E Swier; Andres M Salazar; Michael R Olin
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

10.  Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic.

Authors:  D L Morton; L Wanek; J A Nizze; R M Elashoff; J H Wong
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.